Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
March 17, 2023 9:29 AM 3 min read

The 2019 Playbook As Inflation Data Cools | Our Take On Bank Stocks & High-Quality SaaS

by Blue Line Capital LLC Benzinga Contributor
Follow

We provide free access to the episode's chart pack, including all the data discussed.

Blue Line Capital president Bill Baruch and analyst Jannis Meindl break down the latest fallout from Silicon Valley Bank and regional banks writ large. While most investors were focused on banking stress, we also share the latest on the inflation front.

This week, we cover Morgan Stanley with a juggernaut wealth management asset, United Health, as revenue keeps expanding. We close it out with Adobe among the highest-quality SaaS businesses.

Morgan Stanley - Wealth Management With A Markets Juggernaut

As a systemically important bank, Morgan Stanley (NYSE:MS) has none of the regional banking issues that have shaken the banking space. At less than $11bn of unmarked treasury and MBS losses, liquidity concerns are barely present as the company’s Tier1 Capital ratio of 17.2% exceeds the regulatory minimum under Basel III standards of 14.8%. A concern for banks as a whole is the potential tick-up in delinquencies going forward and the associated economic slowdown that could come with it. Unlike BofA or Wells Fargo, Morgan Stanley’s presence in loans is much lower, which lends itself to more resilience against an economic downturn. Given the company’s wealth management business comprises more than 50% of revenue, deposits shifting into money market funds and other fixed-income products benefits the firm. Heightened activity on the company’s fixed income desk is also encouraging, given that the macro picture remains volatile, lending itself to high trading volumes.

United Health - Insurance Trends With An Aging Population

Growing revenue at an annual rate of 12% in 2022, United Health (OTC:UEEC) has proven resilient against trends of an aging population and the insurance premium payout expected to come with it. United Healthcare, the company’s insurance arm, is complemented by the Optum platform, which breaks down into three segments: 1.) OptumHealth, 2.)OptumRx, 3.) OptumInsight. OptumHealth helps insurance patients to find the specialist or medical provider they need, while OptumRx deals with prescription drugs. OptumInsight aids hospitals and doctors, all integrated into the UnitedHealth Platform. Steady Medical Care and Administrative Ratios suggest customer premiums remain in check despite concerns about delayed procedures in and around Covid. The company trades above peers at an 18.5x NTM P/E but has a significant network effect with 54.99 million insurance members.

Adobe - Investing In High-Quality SaaS

Adobe (NASDAQ:ADBE) is the foundational layer of the digital economy, providing digital media and analytics solutions for all customer tiers, from small businesses to large enterprises. At a 21.8 NTM P/E, we don’t tout the multiple as expensive given the high cash flow visibility and a strong recurring revenue base as a SaaS business. Providing a ~95% gross profit margin in digital media, the incremental cost of providing more services to customers is close to zero while the global digital economy keeps expanding. With a high and expanding free cash flow margin of 42% over the last twelve months, investors are buying a quality business that is facing uncertainty around the Figma acquisition, which could lead to a $1bn break-up fee paid by the company if the DoJ decides to block the merger.

 

Blue Line Capital maintains a long position in Morgan Stanley, United Health, and Adobe.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Penny StocksMarketsbank stockscontributorsExpert Ideas
MS Logo
MSMorgan Stanley
$167.13-%
Overview
ADBE Logo
ADBEAdobe Inc
$262.50-%
UEEC Logo
UEECUnited Health Products Inc
$0.0511-%
MS Logo
MSMorgan Stanley
$167.13-%
Overview
ADBE Logo
ADBEAdobe Inc
$262.50-%
UEEC Logo
UEECUnited Health Products Inc
$0.0511-%
Comments
Loading...